Alan D. Diamond

Array ( [id] => 18435982 [patent_doc_number] => 20230183276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-15 [patent_title] => PYRROLE INHIBITORS OF ERK PROTEIN KINASE, SYNTHESIS THEREOF AND INTERMEDIATES THERETO [patent_app_type] => utility [patent_app_number] => 18/173004 [patent_app_country] => US [patent_app_date] => 2023-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15662 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18173004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20156249 [patent_doc_number] => RE050527 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2025-08-12 [patent_title] => Covalent inhibitors of KRAS G12C [patent_app_type] => reissue [patent_app_number] => 18/109726 [patent_app_country] => US [patent_app_date] => 2023-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 49207 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 329 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18109726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18698612 [patent_doc_number] => 20230329100 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-12 [patent_title] => LIGHT EMITTING ELEMENT AND AMINE COMPOUND FOR THE SAME [patent_app_type] => utility [patent_app_number] => 18/167038 [patent_app_country] => US [patent_app_date] => 2023-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26629 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18167038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20355526 [patent_doc_number] => RE050663 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2025-11-18 [patent_title] => Heterocycle derivatives as pesticides [patent_app_type] => reissue [patent_app_number] => 18/101865 [patent_app_country] => US [patent_app_date] => 2023-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40215 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 1004 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18101865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20114483 [patent_doc_number] => RE050497 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2025-07-22 [patent_title] => (N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide [patent_app_type] => reissue [patent_app_number] => 18/159328 [patent_app_country] => US [patent_app_date] => 2023-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 15450 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18159328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20238888 [patent_doc_number] => RE050594 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2025-09-23 [patent_title] => Spiro[3H-indole-3,2'-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors [patent_app_type] => reissue [patent_app_number] => 18/093145 [patent_app_country] => US [patent_app_date] => 2023-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37715 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18093145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20270071 [patent_doc_number] => RE050634 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2025-10-14 [patent_title] => Diaryl macrocycles as modulators of protein kinases [patent_app_type] => reissue [patent_app_number] => 18/147888 [patent_app_country] => US [patent_app_date] => 2022-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 35750 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18147888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19953966 [patent_doc_number] => RE050453 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2025-06-10 [patent_title] => Indole derivatives as CFTR modulators [patent_app_type] => reissue [patent_app_number] => 18/089898 [patent_app_country] => US [patent_app_date] => 2022-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63499 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18089898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19953968 [patent_doc_number] => RE050455 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2025-06-10 [patent_title] => Pyrazolopyridine derivative having GLP-1 receptor agonist effect [patent_app_type] => reissue [patent_app_number] => 18/077060 [patent_app_country] => US [patent_app_date] => 2022-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 31530 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18077060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20106174 [patent_doc_number] => RE050490 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2025-07-15 [patent_title] => Substituted quinazoline compounds and methods of use thereof [patent_app_type] => reissue [patent_app_number] => 17/985017 [patent_app_country] => US [patent_app_date] => 2022-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 55354 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 378 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17985017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19807669 [patent_doc_number] => RE050319 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2025-03-04 [patent_title] => Compounds and methods for treating cancer [patent_app_type] => reissue [patent_app_number] => 17/984910 [patent_app_country] => US [patent_app_date] => 2022-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14434 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17984910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20576626 [patent_doc_number] => RE050811 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2026-03-10 [patent_title] => Rapid imaging systems and methods for facilitating rapid radiation therapies [patent_app_type] => reissue [patent_app_number] => 17/969338 [patent_app_country] => US [patent_app_date] => 2022-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 23 [patent_no_of_words] => 9697 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17969338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20384751 [patent_doc_number] => RE050681 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2025-12-02 [patent_title] => Ionizable cationic lipid for RNA delivery [patent_app_type] => reissue [patent_app_number] => 17/958932 [patent_app_country] => US [patent_app_date] => 2022-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6680 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17958932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19272644 [patent_doc_number] => RE050031 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2024-07-02 [patent_title] => Chemical formulations for electrochemical device [patent_app_type] => reissue [patent_app_number] => 17/950044 [patent_app_country] => US [patent_app_date] => 2022-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 17 [patent_no_of_words] => 7595 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17950044 [rel_patent_id] =>[rel_patent_doc_number] =>)